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Rationale for the surgical treatment of 
morbid obesity
Morbid obesity correlates with a body mass index (BMI) of 
40 kg/m2.1 Being overweight is associated with numerous 
significant physical problems that are now well recognised. 
It is clear that overweight people of both sexes, especially 
young overweight people, tend to die sooner than their 
lean contemporaries.1,-3 While obesity is a risk factor, 
additional mortality and morbidity is associated with 
co-morbid conditions.4 This applies to non-operated, 
as well as perioperative, mortality and morbidity. These 
conditions were described at the 1985 National Institutes 
of Health Consensus conference, and include diseases 
such as hypertension, hypertrophic cardiomyopathy, 
hyperlipidaemia with ischaemic heart disease (IHD), 
diabetes, cholelithiasis, nonalcoholic steatohepatitis 
(NASH), obstructive sleep apnoea, hypoventilation, 
degenerative arthritis, cancer, polycystic ovarian syndrome 
(PCOS), and psychosocial impairments.4,5
Surgical treatment goals
The only proven method of achieving long-term weight 
control for the morbidly obese is surgical treatment. 
Metabolic surgery involves reducing the size of the 
gastric reservoir, with, or without, a degree of associated 
malabsorption. Eating behaviour improves dramatically.6 
The surgery reduces kilojoule intake, and ensures that the 
patient practises behaviour modification by eating small 
amounts slowly, and experiences enhanced satiety through 
peptide modification. Success of surgical treatment must 
begin with realistic goals and progress through the best 
possible use of well-designed and tested operations. These 
have been determined over the last 30 years, and are 
now standardised, clearly defined procedures, with well- 
recognised and documented outcome results.
Prevention of secondary complications of morbid obesity 
is an important management goal. The option of surgical 
treatment is a rationale supported by the accepted principle 
that diseases that harm call for therapeutic intervention. The 
biological basis for morbid obesity is complex. Recent work 
has demonstrated a genetic component of 25-50%.7 Many 
studies confirm the influence of genetically determined 
proteins produced by the fat cell to be among the many 
mechanisms that have a place in the control of satiety.8-10 
It has also been determined that morbid obesity is a disease 
with a physiological, biochemical, and genetic basis. It is not 
a disorder of willpower, as is sometimes implied. Additional 
contributing causes include environmental, cultural, socio-
economic, and psychological factors.
The long-term mortality rate of gastric bypass procedure 
(GBP) patients is reduced by up to 40%.10,11 Currently, 
the general death rate from bariatric surgery seems to 
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Abstract
Bariatric surgery, despite a relatively short history, has had a tremendous impact on the discipline of surgery. In addition, it 
has had a profound influence on the development of laparoscopic surgery and the treatment of the worldwide epidemic of 
obesity. Contrary to the expectations of the 1990s, that obesity surgery would converge into a single procedure, there has 
been a trend favouring the safest and least invasive surgery on the one hand, and a diligence towards the most effective 
and complicated surgery on the other hand.  The latter, being the biliopancreatic diversion with duodenal switch, requires 
advanced laparoscopic skills and an experienced medical team.  This review will focus predominantly on the laparoscopic 
Roux-en-Y bypass, a recognised procedure which is performed in 80% of patients going to theatre for bariatric surgery.
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vary between 0.2-1%. The rate is lowest for the lap-band 
procedure (0-0.2%) and highest for the biliopancreatic 
diversion (BPD) procedure (0.2-0.8%), with GBP at 0.5%.
A recent Canadian study revealed that severely obese 
patients who chose to undergo bypass surgery reduced 
their risk of premature death by up to 89%, compared to 
equally overweight patients who did not receive surgical 
treatment. Mortality for cardiac disease was reduced from 
5% in the control group to 0.45% in the study group. In 
another study of 66 000 obese patients, about 3% of GBP 
patients (under the age of 40) died within 13.6 years after the 
surgery, compared with 14% of obese patients who were 
not treated surgically. Mortality for this study was 0% in 401 
laparoscopic cases, and 0.6% in 955 open procedures. The 
largest bariatric surgery patient population ever analysed 
(57 918 consenting patients) demonstrated a total mortality 
rate across all procedures of 0.135%,which is equivalent to 
approximately one death per 1 000 patients.  Rates for 90- 
and 30-day all-cause mortality were 0.112% and 0.089%, 
respectively.12
Surgical procedures
Various types of procedures are listed below.
Procedures currently accepted and endorsed by 
international obesity societies (Figure 1) 
•	 Adjustable gastric band (a)
•	 Roux-en-Y gastric bypass (b)
•	 Vertical sleeve gastrectomy (c)
•	 Biliopancreatic diversion with a duodenal switch (d).
Non-accredited procedures
•	 Mini laparoscopic sleeve gastric bypass (Bilroth II 
reconstruction)
•	 Intragastric balloon.
Future and experimental procedures13
•	 EndoBarrier gastrointestinal liner
•	 Implantable Maestro System
•	 Transoral gastroplasty
•	 Transoral gastric volume reduction. 
Banned procedures 
•	 Jejunoileal bypass. 
Gastric bypass procedures
Laparoscopic gastric bypass
The GBP is constructed by creating a small (15- 
30 ml) pouch from the upper stomach, accompanied 
by bypass of the remaining stomach (400- 
1 000 ml). This restricts the volume of food that can be 
eaten. The stomach may be divided into two parts, with 
staples. A total division is usually advocated, to reduce 
the possibility that the two parts of the stomach will fuse 
together (“fistulise”), thereby negating the operation. 
Reconstruction of the gastrointestinal tract is carried 
out to enable drainage of both stomach segments. This 
reconstruction technique produces several variants of the 
operation, which differs in the lengths of small bowel used, 
the degree to which food absorption is affected, and the 
likelihood of adverse nutritional effects. 
Gastric bypass [Roux-en-Y (proximal)] 
The Roux-en-Y laparoscopic GBP was first performed 
in 1993. It is regarded as one of the most difficult limited 
access procedures to perform. However, use of this 
method has greatly popularised the operation, with benefits 
including a shortened hospital stay, reduced discomfort, 
shorter recovery time, less scarring, and minimal risk of an 
incisional hernia.
This procedure is the operation that is least likely to 
result in nutritional difficulties. The small bowel is divided 
approximately 45 cm from the pylorus, and is rearranged 
into a Y configuration, which enables outflow of food from 
the small upper stomach pouch, via a “Roux limb.” In the 
proximal version, the Y intersection is formed near the 
upper (proximal) end of the small bowel. The Roux limb is 
constructed to a length of 80-150 cm, preserving most of the 
small bowel for nutrient absorption. The patient experiences 
a very rapid onset of a sense of stomach fullness, followed 
increasing satiety or lack of interest in food shortly after the 
start of a meal.
Gastric bypass [Roux-en-Y (proximal)]: long loop 
laparoscopic Roux-en-Y gastric bypass
A normal small bowel is 600-1 000 cm in length. As the 
Y connection is moved further down the gastrointestinal 
tract, the amount of bowel that is capable of fully absorbing 
nutrients is progressively reduced, in pursuit of greater 
operation efficacy. The Y connection is formed much closer 
to the lower (distal) end of the small bowel, usually 100-
150 cm from the lower end of the bowel, causing reduced 
a b c d
Figure 1: Accepted and endorsed procedures
(Reproduced with permission from Prof  W Pories)
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absorption (malabsorption) of food, primarily of fats and 
starches, but also of various minerals and fat-soluble 
vitamins. The unabsorbed fats and starches pass into the 
large intestine, where bacterial action produces irritants 
and malodorous gases (steatorrhoea). These increasing 
nutritional effects are associated with a relatively modest 
additional weight loss, and have a limited application.
Loop gastric bypass (“mini gastric bypass”)
At its inception in 1967, the mini GBP was performed using 
a loop of small bowel for reconstruction, rather than a Y 
construction, as is prevalent today. Although this process is 
simpler, it can cause bile and pancreatic enzymes from the 
small bowel to enter the oesophagus, sometimes causing 
severe inflammation and ulceration of either the stomach, 
or the lower oesophagus. If a leak into the abdomen 
occurs, this corrosive fluid can have severe consequences. 
Numerous studies show that the loop reconstruction 
(Billroth II gastrojejunostomy) increases safety when placed 
low on the stomach, but can be disastrous when placed 
adjacent to the oesophagus. Thus, even today, thousands 
of “loops” are used for general surgical procedures, 
such as ulcer surgery, stomach cancer, and injury to the 
stomach. However, bariatric surgeons abandoned use of 
the construction in the 1970s, when it was recognised that 
the risk was not associated with weight management. In 
addition, nutritional abnormalities are very prevalent and 
difficult to manage.
Physiology of the gastric bypass 
procedure
The GBP reduces the size of the stomach by more than 
90%. A normal stomach can stretch, sometimes to a size of 
> 1 500 ml, while the pouch of the GBP may be 30 ml in size. 
The GBP pouch is usually formed from a part of the stomach 
that is least susceptible to stretching. This, in conjunction 
with its small original size, prevents any significant long-
term change in pouch volume. What does change over time 
is the size of the connection between stomach and bowel, 
and the ability of the small bowel to hold a greater volume of 
food. When the patient ingests only a small amount of food, 
the first response is a stretching of the wall of the stomach 
pouch, stimulating nerves that signal to the brain that the 
stomach is full. 
Food is first churned in the stomach before passing into 
the small bowel. When the lumen of the small bowel comes 
into contact with nutrients, a number of hormones are 
released, including cholecystokinin from the duodenum, 
and total peptide YY and glucagon-like peptide 1 from the 
ileum. These hormones inhibit further food intake, and have 
been dubbed “satiety factors”. Ghrelin, a hormone that 
is released in the stomach, stimulates hunger, as well as 
food intake. Changes in circulating hormone levels after 
GBP have been hypothesised to produce reductions in 
food intake and body weight in obese patients. To gain the 
maximum benefit from this physiology, it is important that 
the patient ingests food only at mealtimes (three to four 
small and equally sized meals daily), and avoids snacks 
between meals, which can effectively “bypass the bypass”. 
This requires a change in eating behaviour, and alteration 
of long-acquired eating habits. In almost every case where 
weight gain occurs late after surgery, it is not the capacity 
for a meal that has greatly increased, but rather the pattern 
of constant eating has become fixed. Prospective patients 
need extensive nutritional and psychological counselling in 
order to avail themselves of the merits of how to use their 
newly acquired “tool”. 
Complications of obesity surgery
Intraoperative complications
Complications which occur during bariatric operations can 
be divided into three categories:
•	 Bleeding
•	 Inadvertent injury to the gastrointestinal tract
•	 Stapling misadventures. 
The incidence of intraoperative complications ranges 
between 0-1.4%, at best.
•	 Intraoperative complications can generally be avoided 
by unabated concentration, and careful technique
•	 Injuries can be successfully corrected, or repaired, if 
recognised intraoperatively
•	 The splenectomy rate is about 0.3-0.5%
•	 Intraoperative complications should be rare in expe- 
rienced hands (< 1%).
Early postoperative complications (morbidity)
Complication rates in the early postoperative period, such as 
infection, dehiscence, leaks from staple breakdown, stomal 
stenosis, ulcers, and deep vein thrombosis (DVT) with 
pulmonary embolism, are approximately 4-8%. However, 
the combined risk of the most serious complications 
(gastrointestinal leak and DVT) is < 3%. 
Pulmonary embolism
Pulmonary embolism is the leading cause of perioperative 
death in bariatric surgical patients. The incidence of 
pulmonary embolism is reported to be 0.5% in most 
large series of bariatric operations. Nearly one-third of 
bariatric patients who suffer severe pulmonary embolism 
die. This incidence is lower than for other large surgeries. 
The incidence of severe pulmonary embolism does not 
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seem to be altered much by the routine use of methods of 
perioperative DVT prophylaxis and of anticoagulant therapy, 
but careful preoperative screening, treating contributing risk 
factors, and early mobilisation will further diminish risk.  
Gastrointestinal leaks 
The percentage of gastrointestinal leaks associated with 
primary GBP operations is 1-2%. Leaks are sometimes 
difficult to recognise after GBP, because fever and 
abdominal tenderness are frequently absent. The leukocyte 
count and C-reactive protein are often elevated, but may 
be within normal limits. Left-shoulder pain and anxiety are 
early symptoms. Persistent tachycardia and progressive 
tachypnoea are the most common early signs. Hence, it 
is common to initially suspect pulmonary embolism in a 
patient with a gastric leak. Most surgeons attempt to identify 
leaks using radiographic gastrointestinal contrast studies. 
However, a normal contrast study by no means excludes 
a leak, since extravasation from the gastric staple line is 
often not identified by gastrointestinal contrast studies. An 
isolated left-sided pleural effusion is a common finding on a 
plain chest radiograph. 
Because failure to recognise a leak can result in the patient’s 
death, exploratory laparoscopy or laparotomy should 
be empirically performed in patients with progressive 
tachypnoea and tachycardia in whom pulmonary embolism 
has been ruled out. In patients who are rapidly deteriorating, 
exploratory surgery should be undertaken without 
gastrointestinal radiographs. 
The incidence of leaks following revision procedures is five 
to 10 times higher than after primary operations, presumably 
because of ischaemic damage of the stomach.
Major wound infection
The incidence of major wound infection after GBP is reported 
to be 1-3%. Conversely, seromas in the subcutaneous fatty 
layer are common, with an incidence approaching 40%. 
The potential for wound dehiscence after GBP is greatly 
increased, because of the tension placed on the closure by 
massive overweight. Hence, the abdominal fascia should be 
closed with heavy nonabsorbable sutures. The incidence of 
fascia dehiscence is about 1% in large published series. 
Gastrointestinal bleeding within the 30-day 
perioperative interval 
There are various causes of bleeding, including marginal 
ulceration, ulcers in the bypassed stomach or duodenum, 
gastritis, and bleeding from fresh staple lines. Ulceration of 
the anastomosis occurs in 1-16% of patients.14 
Possible causes of such ulcers are restricted blood supply 
to the anastomosis (compared to the blood supply available 
to the original stomach), in addition to:
•	 Anastomotic tension (technical).
•	 Helicobacter	pylori (should be treated preoperatively if 
identified).
•	 Smoking (should not be allowed pre- or post-surgery).
•	 Use of nonsteroidal anti-inflammatory drugs. Avoidance 
of these, or prescription under strict supervision, can 
drastically reduce incidence.
This condition can be treated with:
•	 Proton-pump inhibitors (e.g. esomeprazole).
•	 Cytoprotection and an acid-buffering agent (e.g. 
sucralfate, very slow healing time).
•	 Temporary restriction of consumption of solid foods. 
Small bowel obstruction 
Within the first several weeks postoperatively, small 
bowel obstruction may occur in 1-2% of patients. Most 
cases of early obstruction can be treated successfully by 
tube decompression, which is best accomplished using 
fluoroscopy. Early obstruction may follow dehiscence of 
the primary trocar site with bowel entrapment, like a Richter 
hernia. 
Cardiorespiratory complications
Cardiorespiratory complications are surprisingly uncommon 
after GBP. Sudden cardiac arrest is quite rare in the 
postoperative period, and death after cardiac arrest is often 
the result of the inability to intubate patients who develop 
acute respiratory distress. Intubation under these difficult 
circumstances may require flexible bronchoscope-assisted 
awake intubation, and may be lifesaving. 
Mortality
Important risk factors for complications and premature 
death following GBP include: 
•	 The physical condition of the patient, including weight 
and specific co-morbid conditions.
•	 The complexity of the bariatric procedure.
•	 The skill and experience of the surgeon.
Laparoscopic GBP typically leads to less pain and fewer 
incisional hernias (1-2%) than open surgery bypass. 
However, laparoscope-assisted surgery is more demanding, 
and inexperienced bariatric surgeons can expect an initial 
increase in peri- and postoperative complications. Mortality 
is affected by complications, which, in turn, are affected by 
pre-existing risk factors, such as degree of obesity, heart 
disease, obstructive sleep apnoea, diabetes mellitus, and 
a history of prior pulmonary embolism. It is also affected 
by the experience of the operating surgeon. The “learning 
curve” for laparoscopic bariatric surgery is estimated to be 
about 125 cases. 
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Intermediate postoperative complications 
In the first three to six months after surgery, as the body 
reacts to rapid weight loss, the patient may experience one 
or more of the following rarely documented changes:
•	 Body aches
•	 Dumping syndrome
•	 Feeling tired or having malaise
•	 Feeling cold when others feel comfortable
•	 Dry skin
•	 Hair thinning and hair loss
•	 Changes in mood and relationship issues.
Some changes are due to a slowing of the body’s metabolism 
from weight loss, and are usually resolved within three to six 
months.
Dumping syndrome
Normally, the pyloric valve at the lower end of the stomach 
regulates the release of food into the bowel. When the GBP 
patient eats sugary food, the sugar passes rapidly into the 
bowel as a result of the absence of a pylorus, giving rise 
to a physiological reaction called the dumping syndrome. 
The body will flood the intestines in an attempt to dilute 
the sugars. An affected person may feel his or her heart 
beating rapidly and forcefully, and break into a cold sweat. 
The patient could be very uncomfortable for about 30-45 
minutes. Diarrhoea may then follow. Traditionally, there 
are two explanations, or two types of dumping, namely, 
mesenteric blood shunting and fluid shifts, or the vasomotor 
type and the hypoglycaemic type, due to excessive insulin 
release following ingestion of high-calorie sugary foods. 
Late postoperative complications
Incisional hernia
Incisional hernia is the most common late complication 
after open GBP, with an incidence of 10-20% in most large 
series. The incidence for laparoscopic surgery is 1-2%.
Internal hernia with obstruction 
This is called a Petersen space herniation. The small bowel 
herniates through the mesenteric defect between the two 
loops of the Y anastomosis. This space should be closed 
at the time of primary surgery. It accounts for only 7% of all 
hernias, but can be a potentially lethal complication due to 
late diagnosis.
Symptomatic gallbladder disease
This ranges from 3-30%. The practice of removing the 
gallbladder prophylactically at the time of surgery has 
been a controversial issue among bariatric surgeons. 
Several surgeons who have recommended prophylactic 
cholecystectomy report histological evidence of gallbladder 
pathology in 90% of cases. It is acceptable practice to 
remove the gallbladder for asymptomatic gallstones at the 
time of bypass surgery, and it is regarded as a standard 
procedure with the BPD and duodenal switch, because of 
the more rapid weight loss.
Vomiting and dehydration
Although vomiting is a side-effect of GBP in the early 
postoperative period, severe intractable vomiting is rare. 
Most cases of severe vomiting are caused by stenosis 
of the outlet stoma. Patients with vomiting who cannot 
tolerate liquids should be hospitalised, and placed on 
intravenous fluids. In many cases, the oedema of the outlet 
stoma, which results from protracted vomiting, will resolve 
without further intervention. Patients who cannot tolerate 
liquids after several days of being nil by mouth and only 
having intravenous fluids should undergo upper endoscopy 
and stomal dilatation, using endoscopic balloons. Stomal 
dilatation is usually successful, except in patients with 
prosthetic stomal reinforcement. Many patients with 
prosthetic stomal reinforcement require re-operation for 
intractable stomal stenosis.
Late disruption of the stapled gastric partition
This breakdown is responsible for patients regaining lost 
weight after GBP. Despite conflicting data, most surgeons 
now routinely divide the stomach during GBP. The incidence 
of staple-line leaks and gastrogastric fistulae after tran-
section is reported to be in the range 1-2%.	
Marginal ulceration after Roux-en-Y gastric bypass
Marginal ulceration incidence ranges from 3-10%. 
These ulcers typically develop on the jejunal side of the 
gastroenterostomy, and are caused by excessive production 
of gastric acid. Marginal ulcers that are not associated with 
disruption of the stapled partition almost always respond 
to proton-pump inhibitors. Conversely, ulcers that occur in 
patients with staple-line breakdown are often intractable to 
medications, and require operative treatment. 
Intestinal obstruction 
Intestinal obstruction is relatively uncommon after GBP, 
but it may be life -threatening. The incidence of small 
bowel obstruction after Roux-en-Y gastric bypass	 and 
other malabsorptive procedures is 2-3%. Because gastric 
capacity is greatly reduced after Roux-en-Y gastric bypass, 
vomiting is often not a prominent symptom.
Although most cases of late small bowel obstruction are 
caused by adhesions, volvulus related to internal hernia is 
a recognised, and occasionally fatal, type of obstruction 
(Petersen hernia), and constitutes 7% of all hernias. Because 
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obstruction of the bypassed bowel may not be obvious 
on plain abdominal radiographs, computed tomography 
scanning should be promptly performed when abdominal 
films are non-diagnostic. 
Aggressive operative treatment is warranted in patients 
whose symptoms do not quickly improve with tube 
decompression.
Nutritional effects of bariatric surgery
After surgery, patients feel full after ingesting only a small 
volume of food, followed soon thereafter by a sense of 
satiety and loss of appetite. Total food intake is markedly 
reduced. As a result of the reduced size of the newly created 
stomach pouch, and reduced food intake, adequate nutrition 
is essential. This includes the number of meals to be taken 
daily, adequate protein intake, and the use of vitamin and 
mineral supplements. Total food intake and the absorbance 
rate of food will rapidly decline after GBP surgery. 
After GBP surgery, there may be an increase in the number 
of acid-producing cells in the lining of the stomach. Acid-
reducing medications can be prescribed to counteract 
the high acidity levels in certain patients. As a result, 
some patients may experience achlorhydia.15 Subsequent 
overgrowth of bacteria may cause the gut ecology to 
change, and can induce recurring nausea and vomiting. 
This can potentially change the absorbance rate of food, 
which contributes to the vitamin and nutrition deficiencies in 
postoperative GBP patients. A lifelong follow-up programme, 
managed by a bariatric clinic with endocrinologists, is 
indicated for all patients.
Protein nutrition
With reduced ability to eat a large volume of food, GPB 
patients must focus on eating their protein requirements 
first, and with each meal. In some cases, a liquid protein 
supplement may be prescribed (e.g. Optifast®).
Calorie nutrition
The significant weight loss that occurs after bariatric 
surgery is due to the patient now taking in much fewer 
calories than the body needs. As the body becomes 
smaller, its energy requirements decrease, while the patient 
simultaneously finds it possible to eat more food. When the 
energy consumed is equal to the calories eaten, weight loss 
will cease. Proximal GBP typically results in the loss of 60-
80% excess body weight, and very rarely leads to excessive 
weight loss.
Vitamins
As the amount of food that will be eaten after GBP is reduced, 
the vitamin content is correspondingly reduced. Therefore, 
supplements should be taken to provide the minimum daily 
requirements of all vitamins and minerals. Absorption of 
some vitamins is not seriously affected after proximal GBP, 
although vitamin B12, calcuim and vitamin D are not well 
absorbed. Intramuscular preparations of B12 will provide 
adequate absorption. After the distal GBP, the fat-soluble 
vitamins A, D and E may not be well absorbed, particularly if 
fat intake is high. Water-dispersible forms of these vitamins 
may be indicated upon physician recommendation.
Minerals
The duodenum is the primary site of absorption of both 
iron and calcium. Supplementation of iron and calcium is 
therefore preferable in all patients. Ferrous sulfate is poorly 
tolerated. Alternative forms of iron (fumarate, gluconate, 
chelates) are less irritating, and probably better absorbed. 
Calcium carbonate preparations should also be avoided. 
Calcium as citrate or gluconate, 1 200 mg as elemental 
calcium, has greater bioavailability, independent of acid in 
the stomach, and is likely to be better absorbed. Vitamin C 
is a co-factor for the conversion of iron from the ferri to ferro 
form for absorption.
Alcohol metabolism
Because of the decreased levels of alcoholic dehydrogenase, 
patients who have undergone GBP surgery will have a lower 
tolerance for alcohol than people who have not undergone 
the surgery. It will also take a GBP patient longer to return to 
a sober level after drinking alcohol than a person who has 
consumed alcohol and who has not had the surgery.16
Pica
Pica is more likely to occur in GBP patients who have a 
history of the condition prior to the surgery.17
Iron
Since iron absorption occurs in the duodenum primarily, 
malabsorption of ingested iron is the primary cause of post-
gastric-bypass iron deficiency. Ferrous sulphate, in normal 
doses, can cause considerable gastrointestinal  distress. 
Alternatives include ferrous fumarate, or a chelated form of 
iron. Patients who are intolerant of oral iron, or who have 
inadequate ferritin levels, will require parenteral iron (e.g. 
Venofer®, Cosmofer®), six monthly. 
Vitamin B12 deficiency 
After GBP surgery, there is a failure to cleave food-bound 
vitamin B12 from its protein moiety in the upper gastric pouch. 
Conversely, crystalline B12 is absorbed normally in the distal 
ileum. Vitamin B12 requires intrinsic factor derived from the 
gastric mucosa to be absorbed. In patients with a small 
gastric pouch, it may not be absorbed, even if supplemented 
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orally, and deficiencies can result in pernicious anemia 
and neuropathies, including Wernicke encephalopathy. 
Sublingual B12 may be adequately absorbed. Vitamin 
B12 deficiency occurs in up to 39% of patients when 
supplementation is not followed. Intramuscular vitamin 
B12 injections (1 000 μg once, and then once every fourth 
month), may be required in the majority of cases.
Folate
Although the aetiology of folate deficiency after GBP 
is unknown, inadequate dietary intake and absorption 
are probably the most common causes of deficiency. 
Deficiencies of this micronutrient can result in anaemia. 
Thiamine 
Thiamine deficiency (also known as beriberi) rarely occurs 
when its absorption site in the jejunum is bypassed. The 
deficiency can also result from inadequate nutritional 
supplements being taken postoperatively. 
Fat malabsorption
Fat malabsorption is a result of  distal long limb GBP. Patients 
who have these procedures are prone to develop diarrhoea, 
malodorous flatus, and deficiencies in fat-soluble vitamins. 
Fat malabsorption is commonly associated with the long 
loop or distal Roux-en-Y gastric bypass and mini bypass, 
but is rarely seen with standard laparascopic Roux-en-Y 
gastric bypass. Fat malabsorption may lead to a deficiency 
of the fat-soluble vitamins, including vitamins A, D, E and K, 
if not replaced. Night blindness, as well as deterioration of 
general eyesight due to deficiency in vitamin A levels, may 
occur in these patients after two years. 
Hyperparathyroidism
Vitamin D deficiency is present in most obese patients prior 
to surgery, resulting from NASH and an inability to form 
25-OH-vitamin D. Inadequate replacement of vitamin D can 
lead to hyperparathyroidism. Inadequate absorption can be 
corrected postoperatively with a dose of 50 000-100 000 U/
week is sufficient to prevent hyperparathyroidism.
Trace elements
Deficiencies in copper, zinc and molybdenum may occur, 
but they are extremely rare.
Conclusion
It is becoming increasingly clear that Roux-en-Y GBP 
is particularly effective for weight loss as a result of 
neurohormonal changes. It is important to bear in mind 
that morbidity remains extremely low post-bariatric surgery, 
provided that the correct procedure is selected for the best 
outcome, and that the patient is well prepared and then 
cared for post-surgery by an expert team. Resolution of 
diabetes and co-morbidities of obesity range from 80-98%. 
An experienced and accredited surgeon and medical team 
are paramount to the success of the patient’s treatment.
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